Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: A comprehensive analysis of the pooled placebo groups of several large clinical trials

被引:76
作者
Roehrborn, CG
Malice, MP
Cook, TJ
Girman, CJ
机构
[1] Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX 75390 USA
[2] MSD Inc, Dept Clin Biostat, Brussels, Belgium
[3] Merck & Co Inc, Rahway, NJ 07065 USA
[4] Merck & Co Inc, Dept Epidemiol, Blue Bell, PA USA
关键词
D O I
10.1016/S0090-4295(01)01155-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To comprehensively evaluate clinical predictors of spontaneous acute urinary retention (AUR) across pooled data of placebo-treated patients from clinical trials conducted in men with lower urinary tract symptoms and clinically diagnosed benign prostatic hyperplasia. Methods. Data from the place bo-treatment groups of several prospective, randomized clinical trials conducted in the United States (n = 3040), Scandinavia, Canada, and worldwide (n = 2295) were combined in the analyses. More than 110 variables were considered individually and in combination as predictors of AUR using logistic regression analysis and classification and regression tree methods with a split-sample approach to cross-validation. Results. The different methods of analysis identified consistent potential predictors of episodes of AUR. When prostate volume was included in the analyses, it was selected as the initial variable discriminating men with and without subsequent AUR. Omitting prostate volume because of its availability in only a subset of men, a logistic model including serum prostate-specific antigen (PSA), urinating more than every 2 hours, symptom problem index, maximum urinary flow rate, and hesitancy of urination had good predictive properties (area under the receiver-operating characteristic curve [AUC] = 0.742 +/- 0.047), as did a model with PSA (AUC = 0.716 +/- 0.045). A classification and regression decision tree with the same variables predicted AUR (AUC = 0.74, sensitivity = 72%, specificity = 67%) as well as did a tree with PSA alone (AUC = 0.70, sensitivity = 75%, specificity = 64%). Conclusions. Prostate volume and serum PSA are strong predictors of AUR in placebo-treated men with lower urinary tract symptoms and clinically diagnosed benign prostatic hyperplasia who were screened for prostate cancer. From more than 110 variables, logistic models and decision trees with PSA alone were comparable to expanded models that included PSA, urinary frequency and hesitancy, flow rate parameters, and symptom problem index, and to a scoring algorithm. UROLOGY 58: 210-216, 2001. (C) 2001, Elsevier Science Inc.
引用
收藏
页码:210 / 216
页数:7
相关论文
共 33 条
[1]   CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY [J].
ANDERSEN, JT ;
EKMAN, P ;
WOLF, H ;
BEISLAND, HO ;
JOHANSSON, JE ;
KONTTURI, M ;
LEHTONEN, T ;
TVETER, K ;
BODKER, A ;
VEDEL, O ;
NORDLING, J ;
POULSEN, AL ;
SCHOU, J ;
HVIDT, V ;
HANSEN, JB ;
MEYHOFF, HH ;
ELDRUP, J ;
HARTWELL, D ;
COLSTRUP, H ;
LYNGDORF, P ;
NIELSEN, AH ;
LARSEN, E ;
WALTER, S ;
LARSEN, EH ;
THYBO, E ;
MOMMSEN, S ;
BROK, KE ;
PALM, L ;
GENSTER, H ;
ANDERSEN, M ;
KAUPPINEN, P ;
RAUVALA, M ;
HAKKINEN, J ;
TAMMELA, T ;
TAINIO, H ;
HYNNINEN, O ;
TIITINEN, J ;
LEHTORANTA, K ;
ALAOPAS, M ;
PERTTILA, I ;
PETAS, A ;
RINTALA, E ;
SALMINEN, R ;
JUUSELA, H ;
HANSSON, E ;
VONWENDT, R ;
TUHKANEN, K ;
TALJA, M ;
NURMI, M ;
PUNTALA, P .
UROLOGY, 1995, 46 (05) :631-637
[2]  
[Anonymous], AHCPR PUBLICATION
[3]   THE NATURAL-HISTORY OF UNTREATED PROSTATISM [J].
BALL, AJ ;
FENELEY, RCL ;
ABRAMS, PH .
BRITISH JOURNAL OF UROLOGY, 1981, 53 (06) :613-616
[4]  
Barry MI, 1995, MED CARE, V33, P145
[5]   RELATIONSHIP OF SYMPTOMS OF PROSTATISM TO COMMONLY USED PHYSIOLOGICAL AND ANATOMICAL MEASURES OF THE SEVERITY OF BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
COCKETT, ATK ;
HOLTGREWE, HL ;
MCCONNELL, JD ;
SIHELNIK, SA ;
WINFIELD, HN .
JOURNAL OF UROLOGY, 1993, 150 (02) :351-358
[6]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[7]   The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists [J].
Barry, MJ ;
Fowler, FJ ;
Bin, L ;
Pitts, JC ;
Harris, CJ ;
Mulley, AG .
JOURNAL OF UROLOGY, 1997, 157 (01) :10-14
[8]  
Birkhoff J D, 1976, Urology, V7, P48, DOI 10.1016/0090-4295(76)90560-4
[9]   VALIDATION OF A SYMPTOMS QUESTIONNAIRE FOR BENIGN PROSTATIC HYPERPLASIA [J].
BOLOGNESE, JA ;
KOZLOFF, RC ;
KUNITZ, SC ;
GRINO, PB ;
PATRICK, DL ;
STONER, E .
PROSTATE, 1992, 21 (03) :247-254
[10]  
Brieman L., 1984, WADSWORTH INC